Qianyu He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qianyu He has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Yanghua Xiao
Shanghai Key Laboratory of Data Science, School of Computer Science, Fudan University, Shanghai, China
2 shared publications - Yongli Bao
National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, China
2 shared publications - Yongyun Zhao
National Engineering Laboratory for Druggable Gene and Protein Screening, College of Life Science, Northeast Normal University, Changchun, 130024, PR China
2 shared publications - Aihua Zhang
School of Information Engineering, Zhengzhou University, Zhengzhou, 450001, China
1 shared publication - Chao Zheng
Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Campbell Family Mental Health Research Institute
1 shared publication - Denghui Gao
NMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University, Changchun 130032, China
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (2) , eadz1874
Three-component synthesis of β-thio tertiary alkylamines from simple alkenes via S H 2 homolytic substitution
Alkene difunctionalization via electrophilic aminyl radical cations offers a straightforward route to complex tertiary alkylamines widely occurring in biologically active molecules. However, only a limited variety of third reaction components have been hitherto introduced because of the challenges in capturing transient C(sp 3 )-centered radical intermediates under acidic conditions, and structurally specific alkenes are usually required. Herein, we report a copper-catalyzed three-component aminothiolation reaction, enabling the first incorporation of S-based functionalities across simple alkenes to synthesize β-thio tertiary alkylamines. This protocol works well for both aryl and unactivated alkenes with a broad functional group compatibility and is applicable to ─SCF 3 , ─SCN, and ─SBz groups. Mechanistic investigations reveal a key bimolecular homolytic (S H 2) substitution process that efficiently traps the nascent C(sp 3 )-centered radical intermediates in acidic media and facilitates the C─S bond formation with high regioselectivity and even primary enantiocontrol. The introduced S-based functionality can improve the performance of pharmaceuticals such as Fentora.
- 9 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (2) , eadz1874
Open AccessThree-component synthesis of β-thio tertiary alkylamines from simple alkenes via S H 2 homolytic substitution
Alkene difunctionalization via electrophilic aminyl radical cations offers a straightforward route to complex tertiary alkylamines widely occurring in biologically active molecules. However, only a limited variety of third reaction components have been hitherto introduced because of the challenges in capturing transient C(sp 3 )-centered radical intermediates under acidic conditions, and structurally specific alkenes are usually required. Herein, we report a copper-catalyzed three-component aminothiolation reaction, enabling the first incorporation of S-based functionalities across simple alkenes to synthesize β-thio tertiary alkylamines. This protocol works well for both aryl and unactivated alkenes with a broad functional group compatibility and is applicable to ─SCF 3 , ─SCN, and ─SBz groups. Mechanistic investigations reveal a key bimolecular homolytic (S H 2) substitution process that efficiently traps the nascent C(sp 3 )-centered radical intermediates in acidic media and facilitates the C─S bond formation with high regioselectivity and even primary enantiocontrol. The introduced S-based functionality can improve the performance of pharmaceuticals such as Fentora.
- Open Access
- 29 April 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , e2309639
Antitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein
Targeting “undruggable” targets with intrinsically disordered structures is of great significance for the treatment of disease. The transcription factor c‐Myc controls global gene expression and is an attractive therapeutic target for multiple types of cancers. However, due to the lack of defined ligand binding pockets, targeted c‐Myc have thus far been unsuccessful. Herein, to address the dilemma of lacking ligands, an efficient and high throughput aptamer screening strategy is established, named polystyrene microwell plate‐based systematic evolution of ligands by exponential enrichment (microwell‐SELEX), and identify the specific aptamer (MA9C1) against c‐Myc. The multifunctional aptamer‐based Proteolysis Targeting Chimeras (PROTAC) for proteolysis of the c‐Myc (ProMyc) is developed using the aptamer MA9C1 as the ligand. ProMyc not only significantly degrades c‐Myc by the ubiquitin‐proteasome system, but also reduces the Max protein, synergistically inhibiting c‐Myc transcriptional activity. Combination of the artificial cyclization and anti‐PD‐L1 aptamer (PA1)‐based delivery system, circular PA1‐ProMyc chimeras achieve tumor regression in the xenograft tumor model, laying a solid foundation for the development of efficacious c‐Myc degrader for the clinic. Therefore, this aptamer‐based degrader provides an invaluable potential degrader in drug discovery and anti‐tumor therapy, offering a promising degrader to overcome the challenge of targeting intractable targets.
- 29 April 2024
- Published by Wiley in Advanced Science
- Vol. 11 (26) , e2309639
Open AccessAntitumor Effect of Anti‐c‐Myc Aptamer‐Based PROTAC for Degradation of the c‐Myc Protein
Targeting “undruggable” targets with intrinsically disordered structures is of great significance for the treatment of disease. The transcription factor c‐Myc controls global gene expression and is an attractive therapeutic target for multiple types of cancers. However, due to the lack of defined ligand binding pockets, targeted c‐Myc have thus far been unsuccessful. Herein, to address the dilemma of lacking ligands, an efficient and high throughput aptamer screening strategy is established, named polystyrene microwell plate‐based systematic evolution of ligands by exponential enrichment (microwell‐SELEX), and identify the specific aptamer (MA9C1) against c‐Myc. The multifunctional aptamer‐based Proteolysis Targeting Chimeras (PROTAC) for proteolysis of the c‐Myc (ProMyc) is developed using the aptamer MA9C1 as the ligand. ProMyc not only significantly degrades c‐Myc by the ubiquitin‐proteasome system, but also reduces the Max protein, synergistically inhibiting c‐Myc transcriptional activity. Combination of the artificial cyclization and anti‐PD‐L1 aptamer (PA1)‐based delivery system, circular PA1‐ProMyc chimeras achieve tumor regression in the xenograft tumor model, laying a solid foundation for the development of efficacious c‐Myc degrader for the clinic. Therefore, this aptamer‐based degrader provides an invaluable potential degrader in drug discovery and anti‐tumor therapy, offering a promising degrader to overcome the challenge of targeting intractable targets.
- Open Access
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 12557-12572
HAUSER: Towards Holistic and Automatic Evaluation of Simile Generation
Qianyu He, Yikai Zhang, Jiaqing Liang, Yuncheng Huang, Yanghua Xiao, Yunwen Chen. Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers). 2023.
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 12557-12572
Open AccessHAUSER: Towards Holistic and Automatic Evaluation of Simile Generation
Qianyu He, Yikai Zhang, Jiaqing Liang, Yuncheng Huang, Yanghua Xiao, Yunwen Chen. Proceedings of the 61st Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers). 2023.
- Open Access
Targeting KRAS in PDAC: A New Way to Cure It?
Pancreatic cancer is one of the most intractable malignant tumors worldwide, and is known for its refractory nature and poor prognosis. The fatality rate of pancreatic cancer can reach over 90%. In pancreatic ductal carcinoma (PDAC), the most common subtype of pancreatic cancer, KRAS is the most predominant mutated gene (more than 80%). In recent decades, KRAS proteins have maintained the reputation of being “undruggable” due to their special molecular structures and biological characteristics, making therapy targeting downstream genes challenging. Fortunately, the heavy rampart formed by KRAS has been broken down in recent years by the advent of KRASG12C inhibitors; the covalent inhibitors bond to the switch-II pocket of the KRASG12C protein. The KRASG12C inhibitor sotorasib has been received by the FDA for the treatment of patients suffering from KRASG12C-driven cancers. Meanwhile, researchers have paid close attention to the development of inhibitors for other KRAS mutations. Due to the high incidence of PDAC, developing KRASG12D/V inhibitors has become the focus of attention. Here, we review the clinical status of PDAC and recent research progress in targeting KRASG12D/V and discuss the potential applications.
Open AccessTargeting KRAS in PDAC: A New Way to Cure It?
Pancreatic cancer is one of the most intractable malignant tumors worldwide, and is known for its refractory nature and poor prognosis. The fatality rate of pancreatic cancer can reach over 90%. In pancreatic ductal carcinoma (PDAC), the most common subtype of pancreatic cancer, KRAS is the most predominant mutated gene (more than 80%). In recent decades, KRAS proteins have maintained the reputation of being “undruggable” due to their special molecular structures and biological characteristics, making therapy targeting downstream genes challenging. Fortunately, the heavy rampart formed by KRAS has been broken down in recent years by the advent of KRASG12C inhibitors; the covalent inhibitors bond to the switch-II pocket of the KRASG12C protein. The KRASG12C inhibitor sotorasib has been received by the FDA for the treatment of patients suffering from KRASG12C-driven cancers. Meanwhile, researchers have paid close attention to the development of inhibitors for other KRAS mutations. Due to the high incidence of PDAC, developing KRASG12D/V inhibitors has become the focus of attention. Here, we review the clinical status of PDAC and recent research progress in targeting KRASG12D/V and discuss the potential applications.
- Open Access
Can Pre-trained Language Models Interpret Similes as Smart as Human?
Simile interpretation is a crucial task in natural language processing. Nowadays, pre-trained language models (PLMs) have achieved state-of-the-art performance on many tasks. However, it remains under-explored whether PLMs can interpret similes or not. In this paper, we investigate the ability of PLMs in simile interpretation by designing a novel task named Simile Property Probing, i.e., to let the PLMs infer the shared properties of similes. We construct our simile property probing datasets from both general textual corpora and human-designed questions, containing 1,633 examples covering seven main categories. Our empirical study based on the constructed datasets shows that PLMs can infer similes' shared properties while still underperforming humans. To bridge the gap with human performance, we additionally design a knowledge-enhanced training objective by incorporating the simile knowledge into PLMs via knowledge embedding methods. Our method results in a gain of 8.58% in the probing task and 1.37% in the downstream task of sentiment classification. The datasets and code are publicly available at https://github.com/Abbey4799/PLMs-Interpret-Simile.
Open AccessCan Pre-trained Language Models Interpret Similes as Smart as Human?
Simile interpretation is a crucial task in natural language processing. Nowadays, pre-trained language models (PLMs) have achieved state-of-the-art performance on many tasks. However, it remains under-explored whether PLMs can interpret similes or not. In this paper, we investigate the ability of PLMs in simile interpretation by designing a novel task named Simile Property Probing, i.e., to let the PLMs infer the shared properties of similes. We construct our simile property probing datasets from both general textual corpora and human-designed questions, containing 1,633 examples covering seven main categories. Our empirical study based on the constructed datasets shows that PLMs can infer similes' shared properties while still underperforming humans. To bridge the gap with human performance, we additionally design a knowledge-enhanced training objective by incorporating the simile knowledge into PLMs via knowledge embedding methods. Our method results in a gain of 8.58% in the probing task and 1.37% in the downstream task of sentiment classification. The datasets and code are publicly available at https://github.com/Abbey4799/PLMs-Interpret-Simile.
- 8 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
A preprocessing method of welding electrical signal
a preprocessing method is proposed for welding electrical signals based on Variational Mode Decomposition (VMD) and Hilbert marginal spectrum. This method solves the problem of poor quality of welding electric signal caused by multifactor interference, especially high frequency interference of inverted power source. In this paper, an acquisition system of the electrical signals of ultra-narrow gap welding was constructed to obtain the electrical signals of welding arc and resistance box load. Based on analyzing the signal characteristics, the signals were decomposed by VMD, and then Hilbert marginal spectrum was used for comparative analysis to filter out the interference noise and realize the preprocessing of welding electrical signal. The results show the proposed method can effectively eliminate the noise while retaining the valuable high-frequency components in the signal, which improves the authenticity of the signal.
- 8 November 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
A preprocessing method of welding electrical signal
a preprocessing method is proposed for welding electrical signals based on Variational Mode Decomposition (VMD) and Hilbert marginal spectrum. This method solves the problem of poor quality of welding electric signal caused by multifactor interference, especially high frequency interference of inverted power source. In this paper, an acquisition system of the electrical signals of ultra-narrow gap welding was constructed to obtain the electrical signals of welding arc and resistance box load. Based on analyzing the signal characteristics, the signals were decomposed by VMD, and then Hilbert marginal spectrum was used for comparative analysis to filter out the interference noise and realize the preprocessing of welding electrical signal. The results show the proposed method can effectively eliminate the noise while retaining the valuable high-frequency components in the signal, which improves the authenticity of the signal.